S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 94 900 KRW 0.74% Market Closed
Market Cap: 1.9T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ST Pharm Co Ltd
Capital Expenditures Peer Comparison

Comparables:
207940
F
220100
L
141080
C
268600
E
456070

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Capital Expenditures
-â‚©45.7B
CAGR 3-Years
-8%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Capital Expenditures
-â‚©692.9B
CAGR 3-Years
-30%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Capital Expenditures
-â‚©2.3B
CAGR 3-Years
26%
CAGR 5-Years
25%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Capital Expenditures
-â‚©2.2B
CAGR 3-Years
35%
CAGR 5-Years
8%
CAGR 10-Years
-16%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Capital Expenditures
-â‚©1.6m
CAGR 3-Years
90%
CAGR 5-Years
73%
CAGR 10-Years
N/A
E
ENCell Co Ltd
KOSDAQ:456070
Capital Expenditures
-â‚©1.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ST Pharm Co Ltd's Capital Expenditures?
Capital Expenditures
-45.7B KRW

Based on the financial report for Jun 30, 2024, ST Pharm Co Ltd's Capital Expenditures amounts to -45.7B KRW.

What is ST Pharm Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-25%

Over the last year, the Capital Expenditures growth was 26%. The average annual Capital Expenditures growth rates for ST Pharm Co Ltd have been -8% over the past three years , -25% over the past five years .

Back to Top